| Title： | Chinese expert consensus on hepatoprotective drug prescription checking |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | Pharmacists, practitioners and other relevant medical personnel in various kinds and grades of facility, and managers of health department and administrative department in charge of medical insurance. |
| Evidence classification method： | The GRADE method was used to grade the quality of evidence and the strength of recommendation. |
| Development unit： | Precision Pharmacy Working Committee of the Chinese Pharmacists Association |
| Registration time: | 2023-05-30 |
| Registration number： | PREPARE-2023CN371 |
| Purpose of the guideline: | The consensus is formulated based on the relevant provisions of laws and regulations and the best available evidence, mainly to provide consistency, uniformity and standardized consensus on prescription checking standards for the clinical rational application of hepatoprotective drugs, promote clinical scientific rational drug use, and ensure the safety of drug use for patients. |
Latest registration
